OMA Guidelines Bundle

Obesity Pharmacotherapy - Obesity Algorithm 2024

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349812

Contents of this Issue

Navigation

Page 20 of 33

21 Some Drug Interactions Contraindications • Monoamine oxidase inhibitors: phentermine is contraindicated during or within 14 days following the administration of these medications because of the risk of hypertensive crisis. • Alcohol: concomitant use of alcohol with phentermine may result in an adverse drug reaction. • Insulin and oral hypoglycemic medications: concomitant use of these medications and phentremine may cause hypoglycemia. A reduction in insulin or oral hypoglycemic medications in people with diabetes mellitus may be required. • Adrenergic Neuron Blocking Drugs: Phentermine may decrease the hypotensive effect of adrenergic neuron blocking drugs. • Hypersensitivity • Pregnancy/nursing • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • Administration during or within 14 days following the administration of monoamine oxidase inhibitors • Uncontrolled hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Concomitant SSRI

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Pharmacotherapy - Obesity Algorithm 2024